Head/Neck Cancer News

Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.

Adults with type 2 diabetes using a GLP-1 receptor agonist have a similar risk for developing thyroid cancer as those using a DPP-IV inhibitor, according to findings published in Thyroid.

The addition of adjuvant nivolumab to standard-of-care radiotherapy and cisplatin improved survival for patients with locally advanced squamous cell carcinoma of the head and neck.

U.S. Surgeon General Vivek Murthy, MD, MBA, issued an advisory today that includes several recommendations designed to reduce the impact of alcohol on cancer incidence and mortality.

The FDA has approved nivolumab and hyaluronidase-nvhy for subcutaneous injection in adults with solid tumors in which nivolumab is indicated, according to a press release.

It’s only the beginning.

Frequent daily coffee and tea drinkers are at lower risk for a variety of head and neck cancers, as well as mouth and throat-related cancers, according to data published in Cancer.

Adults with low-risk thyroid cancer who underwent surgery had significant reductions in cancer-related fear and worry after their procedure compared with before surgery, researchers reported.

Although patients undergoing active surveillance for low-risk cancers generally have a favorable prognosis, oncologists should take steps to manage any anxiety and helplessness patients may be experiencing, according to a viewpoint paper.